美国风湿病学会20标准：临床意义还是统计学意义？ - Suppr

Suppr

超能文献

ACR 20: clinical or statistical significance?

作者信息

Pincus T, Stein C M

机构信息

Division of Rheumatology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.

出版信息

Arthritis Rheum. 1999 Aug;42(8):1572-6. doi: 10.1002/1529-0131(199908)42:8<1572::AID-ANR2>3.0.CO;2-G.

DOI:10.1002/1529-0131(199908)42:8<1572::AID-ANR2>3.0.CO;2-G

PMID:10446853

Abstract

摘要

相似文献

ACR 20: clinical or statistical significance?美国风湿病学会20标准：临床意义还是统计学意义？

Arthritis Rheum. 1999 Aug;42(8):1572-6. doi: 10.1002/1529-0131(199908)42:8<1572::AID-ANR2>3.0.CO;2-G.

[ACR preliminary definition, of improvement in rheumatoid arthritis].[美国风湿病学会（ACR）对类风湿关节炎改善情况的初步定义]

Ryumachi. 1996 Dec;36(6):891-900.

[Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].[甲氨蝶呤耐药类风湿关节炎的循证治疗。传统改善病情抗风湿药的联合应用]

Dtsch Med Wochenschr. 2003 Jan 24;128(4):147-9. doi: 10.1055/s-2003-36869.

Improvement criteria--clinical and statistical significance: comment on the article by Pincus and Stein.改善标准——临床意义和统计学意义：对平卡斯和斯坦因文章的评论

Arthritis Rheum. 2000 Jul;43(7):1658-60. doi: 10.1002/1529-0131(200007)43:7<1657::AID-ANR35>3.0.CO;2-A.

Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.类风湿关节炎治疗反应的预测因素：疾病持续时间的重要性。

Arthritis Rheum. 2000 Jan;43(1):22-9. doi: 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9.

Disease-modifying drugs in rheumatoid arthritis.类风湿关节炎中的病情缓解药物。

Practitioner. 2001 Dec;245(1629):1018-25.

Leflunomide for rheumatoid arthritis.来氟米特用于类风湿关节炎。

Drug Ther Bull. 2000 Jul;38(7):52-4.

[Financial interests characterize published reports on coxiber. Whom can we rely on?].[关于昔布类药物的已发表报告存在经济利益特征。我们能信赖谁？]

Lakartidningen. 2002 Oct 3;99(40):3930-1.

Shouldn't standard rheumatology clinical care be evidence-based rather than eminence-based, eloquence-based, or elegance-based?标准的风湿病临床护理难道不应该基于证据，而不是基于权威、口才或形式吗？

J Rheumatol. 2007 Jan;34(1):1-4.

The systematic study of drug therapy in rheumatoid arthritis.类风湿关节炎药物治疗的系统研究。

J Rheumatol Suppl. 1990 Nov;25:34-8.

引用本文的文献

Impact of MTHFR gene polymorphism on the outcome of methotrexate treatment in a sample of Iraqi rheumatoid arthritis patients.亚甲基四氢叶酸还原酶基因多态性对伊拉克类风湿关节炎患者甲氨蝶呤治疗结局的影响。

Sci Rep. 2024 Jul 2;14(1):15119. doi: 10.1038/s41598-024-65199-7.

Impact of TYMS gene polymorphism on the outcome of methotrexate treatment in a sample of Iraqi rheumatoid arthritis patients - identification of novel single nucleotide polymorphism: Cross-sectional study.TYMS 基因多态性对伊拉克类风湿关节炎患者甲氨蝶呤治疗效果的影响——新的单核苷酸多态性的鉴定：横断面研究。

Medicine (Baltimore). 2024 Jun 7;103(23):e38448. doi: 10.1097/MD.0000000000038448.

Short-Term Efficacy Reliably Predicts Long-Term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model-Based Meta-Analysis.基于模型的荟萃分析表明，短期疗效可可靠预测类风湿关节炎临床试验中的长期临床获益。

J Clin Pharmacol. 2016 Jul;56(7):835-44. doi: 10.1002/jcph.668. Epub 2015 Dec 31.

Simultaneous Exposure-Response Modeling of ACR20, ACR50, and ACR70 Improvement Scores in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol.在接受培塞丽珠治疗的类风湿关节炎患者中，ACR20、ACR50 和 ACR70 改善评分的同时暴露-反应建模。

CPT Pharmacometrics Syst Pharmacol. 2014 Oct 29;3(10):e143. doi: 10.1038/psp.2014.41.

Brief report: rheumatoid arthritis response criteria and patient-reported improvement in arthritis activity: is an American College of Rheumatology twenty percent response meaningful to patients?简要报告：类风湿关节炎反应标准和患者报告的关节炎活动改善：美国风湿病学会 20%反应对患者有意义吗？

Arthritis Rheumatol. 2014 Sep;66(9):2339-43. doi: 10.1002/art.38705.

Etanercept for the treatment of rheumatoid arthritis.依那西普治疗类风湿关节炎。

Cochrane Database Syst Rev. 2013 May 31;2013(5):CD004525. doi: 10.1002/14651858.CD004525.pub2.

Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model.肿瘤坏死因子-α抑制剂治疗类风湿关节炎的成本效用：贝叶斯方法在马尔可夫模型中证据综合的应用。

Pharmacoeconomics. 2012 Jul 1;30(7):575-93. doi: 10.2165/11594990-000000000-00000.

A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis.一项关于鸡 II 型胶原蛋白治疗类风湿关节炎的多中心、双盲、随机、对照 III 期临床试验。

Arthritis Res Ther. 2009;11(6):R180. doi: 10.1186/ar2870. Epub 2009 Dec 1.

Are American College of Rheumatology 50% response criteria superior to 20% criteria in distinguishing active aggressive treatment in rheumatoid arthritis clinical trials reported since 1997? A meta-analysis of discriminant capacities.自1997年以来在类风湿关节炎临床试验报告中，美国风湿病学会50%反应标准在区分积极强化治疗方面是否优于20%标准？一项判别能力的荟萃分析。

Ann Rheum Dis. 2006 Dec;65(12):1602-7. doi: 10.1136/ard.2005.048975. Epub 2006 Feb 27.

Rofecoxib for rheumatoid arthritis.用于类风湿性关节炎的罗非昔布

Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD003685. doi: 10.1002/14651858.CD003685.pub2.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验